Larvol Delta - Aulos-Bioscience-to-Present-Initial-Safety-Data-From-FirstinHuman-Phase-12-Clinical-Trial-of-IL2-Therapeutic-AU007-at-37th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

AU-007 - Aulos Biosci

https://www.businesswire.com/news/home/20221011005239/en/Aulos-Bioscience-to-Present-Initial-Safety-Data-From-First-in-Human-Phase-12-Clinical-Trial-of-IL-2-Therapeutic-AU-007-at-37th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

Oct 11, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next